Clinical Trial Update: A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating adalimumab in combination with chemotherapy and radiotherapy for anaplastic thyroid carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Anaplastic Thyroid Cancers | Phase 1 | Status: WITHDRAWN